StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)

Close on Nov 18, 2026Market cap $30.81MP/E –Yield –

Alterity Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Alterity Therapeutics's pe ratio was 69.7× on Aug 30, 2024, against 66.6× a year earlier. Over the last 5 years it ranged from 0.7× to 69.7×, with a median of 2.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Aug 30, 202469.7×+16.0
2023Dec 29, 202353.7×+52.1
2022Dec 30, 20221.6×−0.7
2021Dec 31, 20212.3×+0.3
2020Dec 31, 20201.9×+1.0
2019Dec 31, 20190.9×–

More Alterity Therapeutics figures

See a number that looks wrong?